List of Tables
Table 1. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Novel Coronavirus Vaccine for Inhalation Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Novel Coronavirus Vaccine for Inhalation, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Novel Coronavirus Vaccine for Inhalation, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Novel Coronavirus Vaccine for Inhalation, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Novel Coronavirus Vaccine for Inhalation, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Novel Coronavirus Vaccine for Inhalation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Novel Coronavirus Vaccine for Inhalation as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Novel Coronavirus Vaccine for Inhalation Price (US$/Unit) by Type (2020-2025)
Table 59. Global Recombinant Novel Coronavirus Vaccine for Inhalation Price (US$/Unit) by Type (2026-2031)
Table 60. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Novel Coronavirus Vaccine for Inhalation Price (US$/Unit) by Application (2020-2025)
Table 69. Global Recombinant Novel Coronavirus Vaccine for Inhalation Price (US$/Unit) by Application (2026-2031)
Table 70. CanSino Bio Company Information
Table 71. CanSino Bio Description and Business Overview
Table 72. CanSino Bio Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CanSino Bio Recombinant Novel Coronavirus Vaccine for Inhalation Product
Table 74. CanSino Bio Recent Developments/Updates
Table 75. Aerogen Company Information
Table 76. Aerogen Description and Business Overview
Table 77. Aerogen Recombinant Novel Coronavirus Vaccine for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Aerogen Recombinant Novel Coronavirus Vaccine for Inhalation Product
Table 79. Aerogen Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Recombinant Novel Coronavirus Vaccine for Inhalation Distributors List
Table 83. Recombinant Novel Coronavirus Vaccine for Inhalation Customers List
Table 84. Recombinant Novel Coronavirus Vaccine for Inhalation Market Trends
Table 85. Recombinant Novel Coronavirus Vaccine for Inhalation Market Drivers
Table 86. Recombinant Novel Coronavirus Vaccine for Inhalation Market Challenges
Table 87. Recombinant Novel Coronavirus Vaccine for Inhalation Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Novel Coronavirus Vaccine for Inhalation
Figure 2. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Share by Type: 2024 & 2031
Figure 4. 18-35 Years Old Product Picture
Figure 5. 35-50 Years Old Product Picture
Figure 6. >50 Years Old Product Picture
Figure 7. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Outpatient Center
Figure 11. Others
Figure 12. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Size (2020-2031) & (US$ Million)
Figure 14. Global Recombinant Novel Coronavirus Vaccine for Inhalation Sales (2020-2031) & (K Units)
Figure 15. Global Recombinant Novel Coronavirus Vaccine for Inhalation Average Price (US$/Unit) & (2020-2031)
Figure 16. Recombinant Novel Coronavirus Vaccine for Inhalation Report Years Considered
Figure 17. Recombinant Novel Coronavirus Vaccine for Inhalation Sales Share by Manufacturers in 2024
Figure 18. Global Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Recombinant Novel Coronavirus Vaccine for Inhalation Players: Market Share by Revenue in Recombinant Novel Coronavirus Vaccine for Inhalation in 2024
Figure 20. Recombinant Novel Coronavirus Vaccine for Inhalation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Recombinant Novel Coronavirus Vaccine for Inhalation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Country (2020-2031)
Figure 23. North America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Country (2020-2031)
Figure 24. United States Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Country (2020-2031)
Figure 27. Europe Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Country (2020-2031)
Figure 28. Germany Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Region (2020-2031)
Figure 35. China Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Country (2020-2031)
Figure 43. Latin America Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Recombinant Novel Coronavirus Vaccine for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Recombinant Novel Coronavirus Vaccine for Inhalation by Type (2020-2031)
Figure 53. Global Revenue Market Share of Recombinant Novel Coronavirus Vaccine for Inhalation by Type (2020-2031)
Figure 54. Global Recombinant Novel Coronavirus Vaccine for Inhalation Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Recombinant Novel Coronavirus Vaccine for Inhalation by Application (2020-2031)
Figure 56. Global Revenue Market Share of Recombinant Novel Coronavirus Vaccine for Inhalation by Application (2020-2031)
Figure 57. Global Recombinant Novel Coronavirus Vaccine for Inhalation Price (US$/Unit) by Application (2020-2031)
Figure 58. Recombinant Novel Coronavirus Vaccine for Inhalation Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed